Welcome to our dedicated page for GBCSD news (Ticker: GBCSD), a resource for investors and traders seeking the latest updates and insights on GBCSD stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect GBCSD's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of GBCSD's position in the market.
Selectis Health announced the appointment of Andrew Sink as an independent director, effective October 17, 2022, filling the vacancy left by Clifford Neuman's resignation as director and secretary. Sink, with over 30 years of real estate experience, is expected to provide valuable insights as the company pursues its business transformation and compliance for a major national exchange listing. His extensive background includes managing private equity funds totaling over $100 million and involvement in transactions exceeding $700 million. CEO Lance Baller emphasizes Sink's crucial role in advancing strategic progress.
Greenwood Village, CO, Oct. 17, 2022 – Selectis Health (OTC: GBCS) will present at the 15th Annual LD Micro Main Event, taking place at the Luxe Sunset Bel Air Hotel in Los Angeles from October 25-27, 2022. Management is set to present on October 25 at 12:30 p.m. PT. The event features over 200 companies and will include live webcasts of presentations. For further inquiries or to arrange meetings with management, contact the investor relations team via email. Selectis provides healthcare services across multiple states, focusing on community relationships and quality care.
Selectis Health reports strong financial results for Q2 2022, with revenue rising 91% year-over-year to $11.5 million and net income reaching $1.0 million.
Recent compliance with SEC reporting obligations follows challenges in auditing previous financial statements. The company has optimized operations by hiring additional financial and healthcare staff, driving improvements in patient occupancy rates across facilities.
Looking ahead, Selectis aims to continue enhancing profitability and operational efficiency while preparing for a potential listing on a national exchange.
Selectis Health, Inc. (OTC: GBCS) reported a revenue increase of over 75% year-over-year for Q1 2022. The company has improved patient census across its facilities while facing delays in financial audits. Interim CFO Christine Lucus has been appointed, and David Furstenberg joins the Board of Directors to enhance corporate governance. Selectis has secured direct billing approvals for all its facilities and aims to eliminate third-party staffing needs by year-end 2022. The company is focused on operational upgrades and maximizing profitability.
Selectis Health, Inc. (OTC: GBCS) has announced a postponement of its scheduled conference call on April 26, 2022, due to additional time needed to finalize the audit of its 2021 financial statements. The company is committed to reporting its fourth quarter and full year 2021 financial results as soon as possible. An update on the timing for the rescheduled conference call will be provided within the next few business days. Selectis operates healthcare facilities across several states, focusing on improving the quality of care for residents.
Selectis Health (OTC: GBCS) will host a conference call on April 26, 2022, at 4:30 p.m. ET to discuss its financial results for Q4 and FY 2021. A press release detailing the results will precede the call. Interested parties can join by dialing 1-877-704-4453 (toll-free) or 1-201-389-0920 (international) and using Conference ID: 13727317. A replay will be available after 7:30 p.m. ET on the same day until May 10, 2022. Selectis Health provides a variety of healthcare services across several states, focusing on strategic community partnerships.
Selectis Health has engaged Gateway Group to enhance its investor relations initiatives. This partnership aims to improve corporate messaging, develop outreach programs, and facilitate connections with institutional investors and analysts. CEO Lance Baller emphasized the strategic timing following operational progress in 2021 and a completed rebranding. The collaboration aims to promote Selectis' growth story to a broader audience and enhance market awareness as it seeks to deepen its presence in the Southcentral and Southeastern U.S. healthcare markets.
Selectis Health reported a net loss of $0.06 million for Q3 2021, equating to $(0.02) per diluted share, a decline from a net income of $0.46 million in Q3 2020. Despite this, total revenue rose by 15.8% year-over-year to $7.32 million. Key developments included a $750,000 fund raise, a 1-for-10 reverse stock split, and refinancing of the Southern Hills mortgage at 2.38% for 35 years. The company faced challenges with COVID-related staffing shortages, incurring $532,030 in agency staffing expenses. Selectis anticipates improved results in 2022 as operational adjustments take effect.
Selectis Health, Inc. (OTC: GBCS) is set to release its third-quarter 2021 financial results on November 16, 2021. A shareholder call will take place on the same day at 4:15 PM EST, where management will discuss the company's performance. Interested parties can join the call by dialing (877)-705-6003 and using confirmation number 13725159. A replay will be available until November 30, 2021. Selectis operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing various rehabilitation and health services.
Selectis Health, Inc. (OTC: GBCSD) announced the successful refinancing of its Southern Hills Continuing Care Retirement Community (CCRC) with a loan of $8,029,800 at a fixed interest rate of 2.38% for 35 years. This refinance supports the facility’s profitability and operational consistency. The company also appointed a new Executive Director to oversee improvements, including renovations that enhance living conditions for residents. Future refinancing efforts for the Eastman facility are underway, promising further positive developments.
